Krishnatreya Manigreeva, Kataki Amal Chandra, Sharma Jagannath Dev, Baishya Nizara, Rahman Tashnin, Bhattcharyya Mouchumee, Das Ashok Kumar, Kalita Manoj
1Department of Cancer Epidemiology and Biostatistics, Dr B. Borooah Cancer Institute, Guwahati, India.
2Patterns of Care and Survival Project, Dr B. Borooah Cancer Institute, Guwahati, India.
Indian J Otolaryngol Head Neck Surg. 2019 Oct;71(Suppl 1):798-804. doi: 10.1007/s12070-018-1556-4. Epub 2018 Dec 27.
To study the survival in patients affected with hypopharyngeal cancer among treatment groups and different stages. Data of hypopharyngeal cancer patients diagnosed from 1st January 2010 to 31st December 2010 was used in the present study. The cases were analyzed for gender, age group distribution, sub-sites at presentation, stage at diagnosis and the type of treatments. Survival from the date of first diagnosis was estimated and hazard ratios were calculated. Survival probability and hazards ratios (HR) were calculated by Kaplan-Meier method and Cox-proportional regression analysis respectively. Censoring of patient who survived longer than 5 years was done. Active follow-up was done for the survival analysis. The study cohort included 217 patients and treatment compliance was observed in 46.9% of cases. The median age at diagnosis was 57 years (range 24-90), 86.2% of cases were locally advanced cases (stage III and IV), pyriform sinus was major sub-site (96%), radiotherapy was main treatment modality alone in 84.8% of cases, median survival was 31 months and 5-year overall survival was 36.9%, and HR for stage IV was 1.9 ( = 0.03, 95% CI - 1.04 to 3.7). In developing setting of North East India, radiotherapy was the main modality of treatment for hypopharyngeal cancer patients, and understanding the clinical parameters and survival of this group of cancers is crucial for its control.
研究下咽癌患者在不同治疗组和不同分期中的生存率。本研究使用了2010年1月1日至2010年12月31日诊断的下咽癌患者数据。对病例进行了性别、年龄组分布、就诊时的亚部位、诊断分期和治疗类型分析。估计从首次诊断日期起的生存率并计算风险比。生存概率和风险比(HR)分别通过Kaplan-Meier法和Cox比例回归分析计算。对存活超过5年的患者进行删失处理。为进行生存分析进行了主动随访。研究队列包括217例患者,46.9%的病例观察到治疗依从性。诊断时的中位年龄为57岁(范围24 - 90岁),86.2%的病例为局部晚期病例(III期和IV期),梨状窝是主要亚部位(96%),84.8%的病例单独以放疗作为主要治疗方式,中位生存期为31个月,5年总生存率为36.9%,IV期的HR为1.9(P = 0.03,95%CI - 1.04至3.7)。在印度东北部的发展中地区,放疗是下咽癌患者的主要治疗方式了解这组癌症的临床参数和生存率对其控制至关重要。